| Suptavumab for the prevention of medically attended respiratory syncytial virus infection in preterm infants EAF Simões, E Forleo-Neto, GP Geba, M Kamal, F Yang, H Cicirello, ... Clinical Infectious Diseases 73 (11), e4400-e4408, 2021 | 116 | 2021 |
| Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses M Mukhamedova, D Wrapp, CH Shen, MSA Gilman, TJ Ruckwardt, ... Immunity 54 (4), 769-780. e6, 2021 | 48 | 2021 |
| Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins CL Hsieh, SA Rush, C Palomo, CW Chou, W Pickens, V Más, JS McLellan Nature communications 13 (1), 1299, 2022 | 38 | 2022 |
| Highly conserved molecular features in IgLONs contrast their distinct structural and biological outcomes H Venkannagari, JM Kasper, A Misra, SA Rush, S Fan, H Lee, H Sun, ... Journal of molecular biology 432 (19), 5287-5303, 2020 | 18 | 2020 |
| Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus SA Rush, G Brar, CL Hsieh, E Chautard, JN Rainho-Tomko, CD Slade, ... Cell Reports 40 (12), 2022 | 14 | 2022 |
| Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein CG Rappazzo, CL Hsieh, SA Rush, ES Esterman, T Delgado, ... Immunity 55 (9), 1710-1724. e8, 2022 | 14 | 2022 |
| Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine E Phung, LA Chang, M Mukhamedova, L Yang, D Nair, SA Rush, ... Science Translational Medicine 14 (650), eabo5032, 2022 | 11 | 2022 |
| Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus A Banerjee, J Huang, SA Rush, J Murray, AD Gingerich, F Royer, ... Proceedings of the National Academy of Sciences 119 (25), e2203326119, 2022 | 11 | 2022 |
| Convergent sequence features of antiviral B cells AA Abu-Shmais, MJ Vukovich, PT Wasdin, YP Suresh, SA Rush, ... bioRxiv, 2023.09. 06.556442, 2023 | 4 | 2023 |
| A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein M Ballegeer, RC van Scherpenzeel, T Delgado, M Iglesias-Caballero, ... Mbio 15 (1), e02122-23, 2024 | 2 | 2024 |
| Antibody sequence determinants of viral antigen specificity AA Abu-Shmais, MJ Vukovich, PT Wasdin, YP Suresh, TM Marinov, ... Mbio 15 (10), e01560-24, 2024 | | 2024 |
| Prefusion-stabilized hmpv f proteins J McLellan, CL Hsieh, S Rush, N Wang US Patent App. 18/411,284, 2024 | | 2024 |
| Prefusion-stabilized hMPV F proteins J McLellan, CL Hsieh, S Rush, N Wang US Patent 11,919,927, 2024 | | 2024 |
| A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein AA Abu-Shmais, L Guo, AM Khalil, RJ Miller, AK Janke, MJ Vukovich, ... bioRxiv, 2024.10. 31.621295, 2024 | | 2024 |
| Repertoire, function, and structure of serological antibodies induced by the R21/Matrix-M malaria vaccine JR McDaniel, WN Voss, G Bowyer, SA Rush, AJ Spencer, D Bellamy, ... bioRxiv, 2024.10. 07.617084, 2024 | | 2024 |
| Structural and biophysical investigations toward engineering a protein subunit vaccine for human metapneumovirus SA Rush | | 2022 |
| Prefusion-stabilized hmpv f proteins J MCLELLAN, CL Hsieh, S Rush, W Nianshuang | | 2022 |
